These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36333566)

  • 1. A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer.
    Feng J; Tang X; Song L; Zhou Z; Jiang Y; Huang Y
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):135-146. PubMed ID: 36333566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
    Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
    Guo X; Wang Y; Zha L; Li H; Qian K
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14745-14760. PubMed ID: 37592033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients.
    Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
    Aging (Albany NY); 2021 Dec; 13(23):25453-25465. PubMed ID: 34897033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
    Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
    BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer.
    Ma M; Li J; Zeng Z; Zheng Z; Kang W
    Front Immunol; 2023; 14():1096488. PubMed ID: 36936957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
    Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
    BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
    Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
    Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and potential function of a novel heme-related LncRNAs signature in gastric cancer.
    Ma S; Liao W; Chen Y; Gan L
    Cell Signal; 2024 Jun; 118():111152. PubMed ID: 38548123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
    Wei J; Zeng Y; Gao X; Liu T
    BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
    Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K
    DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.